Clinical trial
Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance
NCT02534727 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 27, 2016
- Completion date
- December 31, 2020
- Enrollment
- 215 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
non-tuberculosis mycobacteria, tuberculosis